NRx Pharmaceuticals, Inc. (NRXP)
Develops psychiatric medications and treatments for depression, PTSD, and schizophrenia.
$3.50-0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+35.1%
The outlook
NRXP trades at $3.50, positioned midway in its 52-week range with mixed momentum relative to moving averages. Analyst coverage shows a notably bullish lean, with the average price target suggesting substantial upside versus the current level. The stock's overall sentiment scores in the upper-mid range, reflecting cautious optimism among tracked metrics.
What’s behind the score
Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +1100% vs current price
Analyst price target
~12-month · 4 analysts$42.00average target+1100.0% vs now
Now $3.50
Low $25.00High $49.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$149.8M
52-wk high
$5.06
52-wk low
$1.62
50-day avg
$3.95
200-day avg
$2.78
Trailing P/E
—